1. Home
  2. IBO vs LRE Comparison

IBO vs LRE Comparison

Compare IBO & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBO
  • LRE
  • Stock Information
  • Founded
  • IBO 2018
  • LRE 2001
  • Country
  • IBO United States
  • LRE Japan
  • Employees
  • IBO N/A
  • LRE N/A
  • Industry
  • IBO
  • LRE
  • Sector
  • IBO
  • LRE
  • Exchange
  • IBO NYSE
  • LRE Nasdaq
  • Market Cap
  • IBO 22.1M
  • LRE 22.5M
  • IPO Year
  • IBO 2024
  • LRE 2023
  • Fundamental
  • Price
  • IBO $2.12
  • LRE $1.35
  • Analyst Decision
  • IBO
  • LRE
  • Analyst Count
  • IBO 0
  • LRE 0
  • Target Price
  • IBO N/A
  • LRE N/A
  • AVG Volume (30 Days)
  • IBO 23.0K
  • LRE 5.3K
  • Earning Date
  • IBO 03-04-2025
  • LRE 01-01-0001
  • Dividend Yield
  • IBO N/A
  • LRE N/A
  • EPS Growth
  • IBO N/A
  • LRE N/A
  • EPS
  • IBO 0.01
  • LRE 0.29
  • Revenue
  • IBO N/A
  • LRE $117,804,154.00
  • Revenue This Year
  • IBO N/A
  • LRE N/A
  • Revenue Next Year
  • IBO N/A
  • LRE N/A
  • P/E Ratio
  • IBO $175.47
  • LRE $4.61
  • Revenue Growth
  • IBO N/A
  • LRE 8.82
  • 52 Week Low
  • IBO $1.16
  • LRE $1.19
  • 52 Week High
  • IBO $3.25
  • LRE $13.76
  • Technical
  • Relative Strength Index (RSI)
  • IBO N/A
  • LRE 30.61
  • Support Level
  • IBO N/A
  • LRE $1.20
  • Resistance Level
  • IBO N/A
  • LRE $1.70
  • Average True Range (ATR)
  • IBO 0.00
  • LRE 0.10
  • MACD
  • IBO 0.00
  • LRE -0.02
  • Stochastic Oscillator
  • IBO 0.00
  • LRE 25.89

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: